Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
XERIS PHARMACEUTICALS INC (XERS) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/14/2022 SC 13G/A Sessa Capital , L.P. reports a 2.4% stake in XERIS PHARMACEUTICALS INC
10/15/2021 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
10/07/2021 EFFECT Form EFFECT - Notice of Effectiveness:
10/05/2021 4 BORMANN-KENNEDY BARBARA-JEAN ANNE (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 19,650 options to buy @ $12.5, valued at $245.6k
Disposed/sold 20,000 options to buy @ $10, valued at $200k
Disposed/sold 11,228 options to buy @ $4.68, valued at $52.5k
Disposed/sold 11,228 options to buy @ $3.9, valued at $43.8k
10/05/2021 4 SHERMAN JEFFREY W (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 19,650 options to buy @ $12.5, valued at $245.6k
Disposed/sold 20,000 options to buy @ $10, valued at $200k
Disposed/sold 11,228 options to buy @ $4.68, valued at $52.5k
Disposed/sold 11,228 options to buy @ $3.9, valued at $43.8k
10/05/2021 4 Schmid John P. (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 5,659 shares @ $0
Disposed/sold 25,220 options to buy @ $12.5, valued at $315.3k
Disposed/sold 20,000 options to buy @ $10, valued at $200k
Disposed/sold 11,228 options to buy @ $4.68, valued at $52.5k
Disposed/sold 11,228 options to buy @ $3.9, valued at $43.8k
10/05/2021 4 HALKUFF DAWN (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 19,650 options to buy @ $12.5, valued at $245.6k
Disposed/sold 20,000 options to buy @ $10, valued at $200k
Disposed/sold 11,228 options to buy @ $4.68, valued at $52.5k
Disposed/sold 11,228 options to buy @ $3.9, valued at $43.8k
10/05/2021 4 Edick Paul R (CEO) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 197,231 shares @ $0
Disposed/sold 410,833 shares @ $0
Disposed/sold 13,430 shares @ $0
Disposed/sold 668,065 options to buy @ $1.55, valued at $1M
Disposed/sold 69,822 options to buy @ $1.55, valued at $108.2k
Disposed/sold 98,252 options to buy @ $5.93, valued at $582.6k
Disposed/sold 200,000 options to buy @ $13.88, valued at $2.8M
Disposed/sold 400,000 options to buy @ $5.08, valued at $2M
10/05/2021 4 Pieper Steven (CFO) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 23,775 shares @ $0
Disposed/sold 134,333 shares @ $0
Disposed/sold 16,843 options to buy @ $1.55, valued at $26.1k
Disposed/sold 2,640 options to buy @ $1.55, valued at $4.1k
Disposed/sold 14,036 options to buy @ $5.93, valued at $83.2k
Disposed/sold 12,500 options to buy @ $6.37, valued at $79.6k
Disposed/sold 27,891 options to buy @ $4.09, valued at $114.1k
10/05/2021 4 PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 384,780 shares @ $0
Disposed/sold 110,000 shares @ $0
Disposed/sold 11,228 options to buy @ $0.69, valued at $7.7k
Disposed/sold 28,072 options to buy @ $1.55, valued at $43.5k
Disposed/sold 11,266 options to buy @ $1.55, valued at $17.5k
Disposed/sold 14,036 options to buy @ $5.93, valued at $83.2k
Disposed/sold 25,000 options to buy @ $13.88, valued at $347k
Disposed/sold 25,000 options to buy @ $3.94, valued at $98.5k
10/05/2021 4 Hecht Beth (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 26,366 shares @ $0
Disposed/sold 180,000 shares @ $0
Disposed/sold 30,879 options to buy @ $5.93, valued at $183.1k
Disposed/sold 65,295 options to buy @ $12.5, valued at $816.2k
Disposed/sold 3,826 options to buy @ $19, valued at $72.7k
Disposed/sold 32,500 options to buy @ $13.88, valued at $451.1k
Disposed/sold 150,000 options to buy @ $3.94, valued at $591k
10/05/2021 4 JOHNSON KENNETH ERLAND (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 11,250 shares @ $0
Disposed/sold 78,333 shares @ $0
Disposed/sold 33,686 options to buy @ $1.55, valued at $52.2k
Disposed/sold 5,280 options to buy @ $1.55, valued at $8.2k
Disposed/sold 39,633 options to buy @ $5.93, valued at $235k
Disposed/sold 21,401 options to buy @ $19, valued at $406.6k
Disposed/sold 32,500 options to buy @ $13.88, valued at $451.1k
Disposed/sold 100,000 options to buy @ $3.94, valued at $394k
10/05/2021 4 PERSKY MARLA (Director) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 19,650 options to buy @ $12.5, valued at $245.6k
Disposed/sold 20,000 options to buy @ $10, valued at $200k
Disposed/sold 11,228 options to buy @ $4.68, valued at $52.5k
Disposed/sold 11,228 options to buy @ $3.9, valued at $43.8k
10/05/2021 4 Shannon John Patrick Jr (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Disposed/sold 70,496 shares @ $0
Disposed/sold 193,333 shares @ $0
Disposed/sold 160,335 options to buy @ $1.55, valued at $248.5k
Disposed/sold 25,136 options to buy @ $1.55, valued at $39k
Disposed/sold 28,072 options to buy @ $5.93, valued at $166.5k
Disposed/sold 34,977 options to buy @ $12.5, valued at $437.2k
Disposed/sold 80,000 options to buy @ $13.88, valued at $1.1M
Disposed/sold 100,000 options to buy @ $3.94, valued at $394k
10/05/2021 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/05/2021 POS AM Form POS AM - Post-Effective amendments for registration statement:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/05/2021 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
10/05/2021 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Amended and Restated Certificate of Incorporation of the Registrant",
"Amended and Restated Bylaws of the Registrant",
"Second Supplemental Indenture, by and among the Registrant, Xeris Biopharma Holdings, Inc. and U.S. Bank National Association",
"Joinder and Sixth Amendment to Amended and Restated Loan and Security Agreement, by and among the Registrant, Oxford Finance LLC and Silicon Valley Bank"
09/14/2021 8-K Quarterly results
09/13/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/30/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/30/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/26/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/06/2021 425 Form 425 - Prospectuses and communications, business combinations:
08/05/2021 10-Q Quarterly Report for the period ended June 30, 2021
08/05/2021 8-K Quarterly results
07/30/2021 425 Form 425 - Prospectuses and communications, business combinations:
07/30/2021 8-K Quarterly results
07/29/2021 4 Pieper Steven (See Remarks) has filed a Form 4 on XERIS PHARMACEUTICALS INC
Txns: Granted 100,000 shares @ $0
07/29/2021 3 Pieper Steven (See Remarks) has filed a Form 3 on XERIS PHARMACEUTICALS INC
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy